- ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
American Board of Internal Medicine
- Breast Cancer
MD, Medical University of South Carolina
PhD, Medical University of South Carolina
Residency, Internal Medicine
Thomas Jefferson University
Fox Chase Cancer Center
Dr. Morris completed study in the Medical University of South Carolina’s Medical Scientist Training Program with a combine MD/PhD degree in Molecular and Cellular Biology and Pathobiology in 1998. Her PhD dissertation was on anti-apoptotic mechanisms of drug resistance in acute myeloid leukemia. She completed her internship and residency at Thomas Jefferson University Hospital, and her fellowship in Medical Oncology at Fox Chase Cancer Center, in Philadelphia. She returned to the Kimmel Cancer Center at Thomas Jefferson University Hospital in the Solid Tumor Division, where she focused on breast and ovarian cancers, brain tumors, and pancreatic cancers. There, she was PI for several clinical trials and conducted clinical research in breast cancer disparities, for which her work was recognized atBest of ASCO in 2007. She has recently practiced in Northeast Pennsylvania and directed a Family Cancer Risk Assessment Program after completing an Intensive Course in Clinical Genetics at the City of Hope Comprehensive Cancer Center and Beckwith Research Institute. She is a patient advocate for FORCE (Facing Our Risk of Cancer Empowered).
Dr. Morris is a feature editor for the Seminars in Oncology (http://www.seminoncol.org/content/ccp), author of several clinical papers, and a reviewer for several clinical and scientific journals.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Morris did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
1176 Fifth Avenue
New York, NY 10029
27-15 30th Avenue
Astoria, NY 11102